Cargando…
Irisin regulates the expression of BDNF and glycometabolism in diabetic rats
Irisin is a proteolytic product of the fibronectin type III domain-containing protein 5. The aim of the present study was to verify whether irisin is involved in the pathogenesis of diabetic mild cognitive impairment and elucidate the associated mechanisms. Diabetic rats were divided into four group...
Autores principales: | Huang, Lingning, Yan, Sunjie, Luo, Li, Yang, Liyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323232/ https://www.ncbi.nlm.nih.gov/pubmed/30569121 http://dx.doi.org/10.3892/mmr.2018.9743 |
Ejemplares similares
-
Identification of independent risk factors for diabetic neuropathy progression in patients with type 2 diabetes mellitus
por: Huang, Linjing, et al.
Publicado: (2021) -
Type 2 Diabetic Rats on Diet Supplemented With Chromium Malate Show Improved Glycometabolism, Glycometabolism-Related Enzyme Levels and Lipid Metabolism
por: Feng, Weiwei, et al.
Publicado: (2015) -
Relationship between Hyponatremia and Peripheral Neuropathy in Patients with Diabetes
por: Zhang, Yongze, et al.
Publicado: (2021) -
Improvement of Lipotoxicity-Induced Islet β Cellular Insulin Secretion Disorder by Osteocalcin
por: Zhang, Yafang, et al.
Publicado: (2022) -
Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose–response and curative effects study
por: Feng, Weiwei, et al.
Publicado: (2015)